Trial intelligence / Profile preview

MCPA study: dl-methylephedrine effects on athletic performance

jRCTs031220492Completed

Sponsor
Japan Anti-Doping Agency
Start
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial comparing dl-methylephedrine 150 mg with Placebo (2 arms). Started Jan 2023; status: completed.

02

Drugs

methylephedrine

Beyond the preview

Go deeper on jRCTs031220492.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031220492.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call